The Effect of Volunteer-Engaged Lifestyle Optimisation Via ICOPE on Sarcopenia in Older Adults (VELO-S)
- Sponsor
- The University of Hong Kong
- Study ID
- NCT07345832
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Fall Prevention in Healthy Aging
- Frailty
- Frailty Syndrome
- Malnutrition Elderly
- Sarcopenia
- Sarcopenia in Elderly
Eligibility Criteria
- Sex
- ALL
- Age
- 60 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Volunteer-Engaged Lifestyle Optimisation via ICOPE for Sarcopenia program (VELO-S) — BEHAVIORALA series of interactive lifestyle empowerment workshops will be conducted at community centres to translate the care plan into sustainable behavioural changes. In addition to one session for individualised care planning, five 90-minute, bi-weekly, in-person, volunteer-enhanced interactive workshops led by nurses will be delivered to equip older adults with knowledge and practical skills to manage sarcopenia. Before interactive workshops, a brief orientation and strategic planning session will focus on the health coach's role, introduce participants to them, and pair each participant with a coach. Participants will be assisted by a corresponding health coach throughout the 12-week intervention workshop.
- Attention control — BEHAVIORALThe attention control group receives six session meeting covering topics unrelated to sarcopenia, it will be delivered in a small-group with comparable duration and frequency of contact and engagement to those in the intervention group
Study Details
Sarcopenia prevention and management are highly prioritised goals in the Healthy Ageing agenda. The study aims to: 1) evaluate the effects of the digital-enhanced, volunteer-engaged collaborative care pathway to improve sarcopenia, reduce fall risk, and increase health-related quality of life (HRQL) among community-dwelling older adults with risk of, or diagnosed with, sarcopenia; 2) evaluate whether the volunteers who received health coach capacity training and supported the intervention experienced health benefits across time; 3) explore the engagement experiences and perceived effects of elderly participants with sarcopenia during the program; 4) evaluate the intervention implementation process and effects from the perspectives of social care workers.
Key Dates
- First listed
- Jan 16, 2026
- Start date
- Jun 1, 2026
- Status verified
- Mar 2026
- Primary completion
- Mar 30, 2027
- Completion
- Sep 30, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: Volunteer-Engaged Lifestyle Optimisation via ICOPE for Sarcopenia program (VELO-S)This digital program incorporates a 12-week, volunteer-engaged lifestyle optimisation programme grounded in WHO ICOPE and delivered through an ICOPE-based critical pathway for nutrition and exercise.
- Active Comparator: Attention controlTo control for the non-specific effects of receiving attention and social interaction on outcomes, participants in the attention control group will receive a comparable duration and frequency of contact and engagement to those in the intervention group. The attention-control group will receive six sessions delivered in a small-group format. The six sessions will be delivered topics that unrelated to sarcopenia, including social health, mental health, cognitive health, insomnia and medication safety. Educational materials will be distributed to participants. Participants will be invited to attend the sessions either by a face-to-face meeting or by telephone call (around 60 minutes) with the research team to talk about the aforementioned topics, ensuring comparable exposure to social engagement and attention.
Primary Outcome Measure
Appendicular skeletal muscle mass index (ASMI) [ Time Frame: Baseline (T0), 3 months (T1), and 6 months (T2) ]
Central Contacts
- Doris Sau Fung YU, PhD852-3917-6319
Related Studies
- Safety, Efficacy of FFP From Healthy Donors to Ameliorate Frailty and Enhance Immune Function in Older IndividualsPHASE1/PHASE2 · Enrolling By Invitation · Dipnarine Maharaj · Boynton Beach, Florida
- Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal CancerRecruiting · Wake Forest University Health Sciences · Millville, Delaware
- Frailty and Physician Modified Fenestrated Endograft for Thoracoabdominal Aortic PathologiesRecruiting · University of Southern California · Los Angeles, California
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) FrailtyRecruiting · University of California, Los Angeles · Los Angeles, California